Skip to main content
Erschienen in: Der Internist 7/2003

01.07.2003 | Schwerpunkt: Endorganschäden

Die diabetischen Folgeerkrankungen

Mikro- und makroangiopathische Organschäden

verfasst von: U. D. Lichtenauer, J. Seissler, Prof. Dr. W. A. Scherbaum

Erschienen in: Die Innere Medizin | Ausgabe 7/2003

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die diabetesassoziierten Folgeerkrankungen tragen zu einer erheblichen Verminderung der Lebensqualität und deutlichen Erhöhung der Mortalität bei. Die Folgeschäden manifestieren sich im Sinne einer Makroangiopathie als koronare Herzkrankheit, periphere arterielle Verschlusskrankheit und zerebrovaskuläre Insuffizienz. Außerdem besteht ein hohes Risiko für eine diabetische Nephropathie, Neuropathie und Retinopathie, mit der Gefahr der Entwicklung einer chronischen Niereninsuffizienz, eines Visusverlusts oder eines diabetischen Fußsyndroms. Obwohl die chronische Hyperglykämie einen eigenständigen Risikofaktor für makro- und mikroangiopathische Komplikationen darstellt, steigern assoziierte Erkrankungen wie die arterielle Hypertonie und Hypercholesterinämie das Mortalitätsrisiko in einem erheblichen Maße. In den letzten Jahren wurden deshalb neue Konzepte für die Verbesserung der Diagnose, Therapie und Langzeitbetreuung von Diabetikern erstellt, die neben einer normnahen Blutzuckereinstellung die konsequente Behandlung begleitender Risikofaktoren beinhaltet. Durch diese optimierte Betreuung kann die Lebensqualität und Prognose von Patienten mit Diabetes mellitus verbessert werden.
Literatur
1.
Zurück zum Zitat (1995) Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 75: 894–903CrossRefPubMed (1995) Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 75: 894–903CrossRefPubMed
2.
Zurück zum Zitat American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February 1998, Miami, Florida. Diabetes Care 21: 1551–1559PubMed American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February 1998, Miami, Florida. Diabetes Care 21: 1551–1559PubMed
3.
Zurück zum Zitat UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703–713PubMed UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703–713PubMed
4.
Zurück zum Zitat Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ (1998) Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21: 1071–1075PubMed Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ (1998) Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21: 1071–1075PubMed
5.
Zurück zum Zitat Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501PubMed Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501PubMed
6.
Zurück zum Zitat Asplund K, Hagg E, Helmers C, Lithner F, Strand T, Wester PO (1980) The natural history of stroke in diabetic patients. Acta Med Scand 207: 417–424PubMed Asplund K, Hagg E, Helmers C, Lithner F, Strand T, Wester PO (1980) The natural history of stroke in diabetic patients. Acta Med Scand 207: 417–424PubMed
7.
Zurück zum Zitat Backonja M, Beydoun A, Edwards KR et al. (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280: 1831–1836PubMed Backonja M, Beydoun A, Edwards KR et al. (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280: 1831–1836PubMed
8.
Zurück zum Zitat Biesenbach G, Grafinger P, Janko O, Zazgornik J (1997) Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients. Clin Nephrol 48: 146–150PubMed Biesenbach G, Grafinger P, Janko O, Zazgornik J (1997) Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients. Clin Nephrol 48: 146–150PubMed
10.
Zurück zum Zitat Diaz R, Paolasso EA, Piegas LS et al. (1998) Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 98: 2227–2234PubMed Diaz R, Paolasso EA, Piegas LS et al. (1998) Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 98: 2227–2234PubMed
11.
Zurück zum Zitat Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, Lindgarde F (2003) Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 52: 442–447PubMed Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, Lindgarde F (2003) Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 52: 442–447PubMed
12.
Zurück zum Zitat Faronato PP, Maioli M, Tonolo G et al. (1997) Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia 40: 816–823CrossRefPubMed Faronato PP, Maioli M, Tonolo G et al. (1997) Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia 40: 816–823CrossRefPubMed
13.
Zurück zum Zitat Fava S, Azzopardi J, Muscat HA, Fenech FF (1993) Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 16: 1615–1618PubMed Fava S, Azzopardi J, Muscat HA, Fenech FF (1993) Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 16: 1615–1618PubMed
14.
Zurück zum Zitat Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42–47PubMed Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42–47PubMed
15.
Zurück zum Zitat Forsblom CM, Sane T, Groop PH et al. (1998) Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 41: 1253–1262CrossRefPubMed Forsblom CM, Sane T, Groop PH et al. (1998) Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 41: 1253–1262CrossRefPubMed
16.
Zurück zum Zitat Frei U, Schober-Halstenberg HJ (1999) Annual report of the German Renal Registry 1998. QuaSi-Niere Task Group for Quality Assurance in Renal Replacement Therapy. Nephrol Dial Transplant 14: 1085–1090CrossRefPubMed Frei U, Schober-Halstenberg HJ (1999) Annual report of the German Renal Registry 1998. QuaSi-Niere Task Group for Quality Assurance in Renal Replacement Therapy. Nephrol Dial Transplant 14: 1085–1090CrossRefPubMed
17.
Zurück zum Zitat Gerritsen J, Dekker JM, TenVoorde BJ et al. (2001) Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24: 1793–1798PubMed Gerritsen J, Dekker JM, TenVoorde BJ et al. (2001) Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24: 1793–1798PubMed
18.
Zurück zum Zitat Graf M, Halbach E, Kaufmann H (1999) Causes of blindness in Hessia in 1996. Klin Monatsbl Augenheilkd 215: 50–55PubMed Graf M, Halbach E, Kaufmann H (1999) Causes of blindness in Hessia in 1996. Klin Monatsbl Augenheilkd 215: 50–55PubMed
19.
Zurück zum Zitat Grau AJ, Weimar C, Buggle F et al. (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 32: 2559–2566PubMed Grau AJ, Weimar C, Buggle F et al. (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 32: 2559–2566PubMed
20.
Zurück zum Zitat Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229–234PubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229–234PubMed
21.
Zurück zum Zitat Harati Y, Gooch C, Swenson M et al. (1998) Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50: 1842–1846PubMed Harati Y, Gooch C, Swenson M et al. (1998) Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50: 1842–1846PubMed
22.
Zurück zum Zitat Haslbeck M, Corvin S, Luft D et al. (2002) Diagnose, Therapie und Verlaufskontrolle der autonomen diabetischen Neuropathien. In: Scherbaum WA, Landgraf R (Hrsg) Evidenzbasierte Diabetes-Leitlinien. Deutsche Diabetes Gesellschaft Haslbeck M, Corvin S, Luft D et al. (2002) Diagnose, Therapie und Verlaufskontrolle der autonomen diabetischen Neuropathien. In: Scherbaum WA, Landgraf R (Hrsg) Evidenzbasierte Diabetes-Leitlinien. Deutsche Diabetes Gesellschaft
23.
Zurück zum Zitat Haslbeck M, Redaélli M, Parandeh-Shab F et al. (2000) Diagnostik, Therapie und Verlaufskontrolle der sensomotorischen diabetischen Neuropathien. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien. Deutsche Diabetes Gesellschaft Haslbeck M, Redaélli M, Parandeh-Shab F et al. (2000) Diagnostik, Therapie und Verlaufskontrolle der sensomotorischen diabetischen Neuropathien. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien. Deutsche Diabetes Gesellschaft
24.
Zurück zum Zitat Hasslacher C (1989) Diabetic nephropathy: structural-functional relationships. Contrib Nephrol 73: 24–28PubMed Hasslacher C (1989) Diabetic nephropathy: structural-functional relationships. Contrib Nephrol 73: 24–28PubMed
25.
Zurück zum Zitat Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P (1993) Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 1051–1056PubMed Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P (1993) Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 1051–1056PubMed
26.
Zurück zum Zitat Hasslacher C, Gandjour A, Redaélli M et al. (2000) Diagnose, Therapie und Verlaufskontrolle der Diabetischen Nephropathie. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien. Deutsche Diabetes Gesellschaft Hasslacher C, Gandjour A, Redaélli M et al. (2000) Diagnose, Therapie und Verlaufskontrolle der Diabetischen Nephropathie. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien. Deutsche Diabetes Gesellschaft
27.
Zurück zum Zitat Howard BV, Robbins DC, Sievers ML et al. (2000) LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler Thromb Vasc Biol 20: 830–835PubMed Howard BV, Robbins DC, Sievers ML et al. (2000) LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler Thromb Vasc Biol 20: 830–835PubMed
28.
Zurück zum Zitat Kannel WB, McGee DL (1979) Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59: 8–13PubMed Kannel WB, McGee DL (1979) Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59: 8–13PubMed
29.
Zurück zum Zitat Kempler P, Varadi A, Szalay F (1992) Autonomic neuropathy and prolongation of QT-interval in liver disease. Lancet 340: 318 Kempler P, Varadi A, Szalay F (1992) Autonomic neuropathy and prolongation of QT-interval in liver disease. Lancet 340: 318
30.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520–526PubMed Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520–526PubMed
31.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527–532PubMed Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527–532PubMed
32.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 91: 1464–1474PubMed Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 91: 1464–1474PubMed
33.
Zurück zum Zitat Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, Holman RR (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33: 1776–1781CrossRefPubMed Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, Holman RR (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33: 1776–1781CrossRefPubMed
34.
Zurück zum Zitat Krumpaszky HG, Ludtke R, Mickler A, Klauss V, Selbmann HK (1999) Blindness incidence in Germany. A population-based study from Wurttemberg-Hohenzollern. Ophthalmologica 213: 176–182CrossRefPubMed Krumpaszky HG, Ludtke R, Mickler A, Klauss V, Selbmann HK (1999) Blindness incidence in Germany. A population-based study from Wurttemberg-Hohenzollern. Ophthalmologica 213: 176–182CrossRefPubMed
35.
Zurück zum Zitat Kuhlmann A (2001) Podozytenschaden bei experimentellem Diabetes—Effekt von ACE- und Endothelin-Hemmung. Pathologie 22: A226 Kuhlmann A (2001) Podozytenschaden bei experimentellem Diabetes—Effekt von ACE- und Endothelin-Hemmung. Pathologie 22: A226
36.
Zurück zum Zitat Laakso M (1999) Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48: 937–942PubMed Laakso M (1999) Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48: 937–942PubMed
37.
Zurück zum Zitat Larkins RG, Dunlop ME (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35: 499–504PubMed Larkins RG, Dunlop ME (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35: 499–504PubMed
38.
Zurück zum Zitat Lowel H, Koenig W, Engel S, Hormann A, Keil U (2000) The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 43: 218–226 Lowel H, Koenig W, Engel S, Hormann A, Keil U (2000) The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 43: 218–226
39.
Zurück zum Zitat Mackaay AJ, Beks PJ, Dur AH, Bischoff M, Scholma J, Heine RJ, Rauwerda JA (1995) The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and non-diabetic subjects. Eur J Vasc Endovasc Surg 9: 170–175PubMed Mackaay AJ, Beks PJ, Dur AH, Bischoff M, Scholma J, Heine RJ, Rauwerda JA (1995) The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and non-diabetic subjects. Eur J Vasc Endovasc Surg 9: 170–175PubMed
40.
Zurück zum Zitat Malmberg K (1997) Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314: 1512–1515PubMed Malmberg K (1997) Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314: 1512–1515PubMed
41.
Zurück zum Zitat McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RF (1995) The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 18: 216–219 McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RF (1995) The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 18: 216–219
42.
Zurück zum Zitat Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89–93PubMed Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89–93PubMed
43.
Zurück zum Zitat Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA (1999) Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159: 1931–1937CrossRefPubMed Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA (1999) Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159: 1931–1937CrossRefPubMed
44.
Zurück zum Zitat Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L (1993) Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group. Ann Epidemiol 3: 493–499PubMed Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L (1993) Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group. Ann Epidemiol 3: 493–499PubMed
45.
Zurück zum Zitat Ohkubo Y, Kishikawa H, Araki E et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103–117PubMed Ohkubo Y, Kishikawa H, Araki E et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103–117PubMed
46.
Zurück zum Zitat Quinn M, Angelico MC, Warram JH, Krolewski AS (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940–945PubMed Quinn M, Angelico MC, Warram JH, Krolewski AS (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940–945PubMed
47.
Zurück zum Zitat Reichard P, Pihl M, Rosenqvist U, Sule J (1996) Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up. Diabetologia 39: 1483–1488CrossRefPubMed Reichard P, Pihl M, Rosenqvist U, Sule J (1996) Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up. Diabetologia 39: 1483–1488CrossRefPubMed
48.
Zurück zum Zitat Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis 34: 795–808PubMed Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis 34: 795–808PubMed
49.
Zurück zum Zitat Ritz E, Stefanski A (1996) Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27: 167–194PubMed Ritz E, Stefanski A (1996) Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27: 167–194PubMed
50.
Zurück zum Zitat Rodriguez BL, D'Agostino R, Abbott RD et al. (2002) Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: A comparison of incidence and risk factor effects. Stroke 33: 230–236CrossRefPubMed Rodriguez BL, D'Agostino R, Abbott RD et al. (2002) Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: A comparison of incidence and risk factor effects. Stroke 33: 230–236CrossRefPubMed
51.
Zurück zum Zitat Ruhnau KJ, Meissner HP, Finn JR et al. (1999) Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 16: 1040–1043CrossRefPubMed Ruhnau KJ, Meissner HP, Finn JR et al. (1999) Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 16: 1040–1043CrossRefPubMed
52.
Zurück zum Zitat Savage PJ (1996) Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann Intern Med 124: 123–126PubMed Savage PJ (1996) Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann Intern Med 124: 123–126PubMed
53.
Zurück zum Zitat Sawicki PT (1997) Lisinopril and albumin excretion in diabetes. Lancet 350: 662–664CrossRef Sawicki PT (1997) Lisinopril and albumin excretion in diabetes. Lancet 350: 662–664CrossRef
54.
Zurück zum Zitat Scherbaum WA, Landgraf R (2002) Praxisleitlinien der Deutschen Diabetes Gesellschaft. Diabetes Stoffwechsel 11: 1–30 Scherbaum WA, Landgraf R (2002) Praxisleitlinien der Deutschen Diabetes Gesellschaft. Diabetes Stoffwechsel 11: 1–30
55.
Zurück zum Zitat Schiel R, Muller UA, Sprott H, Schmelzer A, Mertes B, Hunger-Dathe W, Ross IS (1997) The JEVIN trial: a population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990. Diabetologia 40: 1350–1357CrossRefPubMed Schiel R, Muller UA, Sprott H, Schmelzer A, Mertes B, Hunger-Dathe W, Ross IS (1997) The JEVIN trial: a population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990. Diabetologia 40: 1350–1357CrossRefPubMed
56.
Zurück zum Zitat Shaw JE (1999) The epidemiology of diabetic neuropathy. Diabetes Rev 7: 245–252 Shaw JE (1999) The epidemiology of diabetic neuropathy. Diabetes Rev 7: 245–252
57.
Zurück zum Zitat Sievers ML, Bennett PH, Nelson RG (1999) Effect of glycemia on mortality in Pima Indians with type 2 diabetes. Diabetes 48: 896–902PubMed Sievers ML, Bennett PH, Nelson RG (1999) Effect of glycemia on mortality in Pima Indians with type 2 diabetes. Diabetes 48: 896–902PubMed
58.
Zurück zum Zitat Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K (1993) Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care 16: 16–20 Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K (1993) Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care 16: 16–20
59.
Zurück zum Zitat Sima AA, Thomas PK, Ishii D, Vinik A (1997) Diabetic neuropathies. Diabetologia 40 (Suppl 3): B74–B77CrossRefPubMed Sima AA, Thomas PK, Ishii D, Vinik A (1997) Diabetic neuropathies. Diabetologia 40 (Suppl 3): B74–B77CrossRefPubMed
60.
Zurück zum Zitat Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434–444PubMed Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434–444PubMed
61.
Zurück zum Zitat Standl E, Fuchs C, Parandeh-Shab F et al. (2000) Management der Hypertonie beim Patienten mit Diabetes mellitus. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien. Deutsche Diabetes-Gesellschaft Standl E, Fuchs C, Parandeh-Shab F et al. (2000) Management der Hypertonie beim Patienten mit Diabetes mellitus. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien. Deutsche Diabetes-Gesellschaft
62.
Zurück zum Zitat Stone PH, Muller JE, Hartwell T et al. (1989) The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol 14: 49–57PubMed Stone PH, Muller JE, Hartwell T et al. (1989) The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol 14: 49–57PubMed
63.
Zurück zum Zitat Taubert G, Winkelmann BR, Schleiffer T et al. (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145: 285–291CrossRefPubMed Taubert G, Winkelmann BR, Schleiffer T et al. (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145: 285–291CrossRefPubMed
64.
Zurück zum Zitat Tierney S, Fennessy F, Hayes DB (2000) ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease. BMJ 320: 1262–1265CrossRefPubMed Tierney S, Fennessy F, Hayes DB (2000) ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease. BMJ 320: 1262–1265CrossRefPubMed
65.
Zurück zum Zitat Toeller M, Buyken A, Heitkamp G et al. (1997) Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study. Diabetologia 40: 1219–1226CrossRefPubMed Toeller M, Buyken A, Heitkamp G et al. (1997) Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study. Diabetologia 40: 1219–1226CrossRefPubMed
66.
Zurück zum Zitat Vlassara H, Cai W, Crandall J et al. (2002) Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 99: 15.596–15.601CrossRef Vlassara H, Cai W, Crandall J et al. (2002) Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 99: 15.596–15.601CrossRef
67.
Zurück zum Zitat Vlassara H, Fuh H, Donnelly T, Cybulsky M (1995) Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1: 447–456PubMed Vlassara H, Fuh H, Donnelly T, Cybulsky M (1995) Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1: 447–456PubMed
68.
Zurück zum Zitat Wilton TD (1974) Tegretol in the treatment of diabetic neuropathy. S Afr Med J 48: 869–872PubMed Wilton TD (1974) Tegretol in the treatment of diabetic neuropathy. S Afr Med J 48: 869–872PubMed
69.
Zurück zum Zitat Woodfield SL, Lundergan CF, Reiner JS et al. (1996) Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 28: 1661–1669CrossRefPubMed Woodfield SL, Lundergan CF, Reiner JS et al. (1996) Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 28: 1661–1669CrossRefPubMed
70.
Zurück zum Zitat Ziegler D (1994) Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 10: 339–383PubMed Ziegler D (1994) Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 10: 339–383PubMed
71.
Zurück zum Zitat Ziegler D, Gries FA, Muhlen H, Rathmann W, Spuler M, Lessmann F (1993) Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab 19: 143–151PubMed Ziegler D, Gries FA, Muhlen H, Rathmann W, Spuler M, Lessmann F (1993) Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab 19: 143–151PubMed
72.
Zurück zum Zitat Ziegler D, Hanefeld M, Ruhnau KJ et al. (1999) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 22: 1296–1301PubMed Ziegler D, Hanefeld M, Ruhnau KJ et al. (1999) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 22: 1296–1301PubMed
73.
Zurück zum Zitat Zuanetti G, Latini R, Maggioni AP, Franzosi M, Santoro L, Tognoni G (1997) Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation 96: 4239–4245PubMed Zuanetti G, Latini R, Maggioni AP, Franzosi M, Santoro L, Tognoni G (1997) Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation 96: 4239–4245PubMed
Metadaten
Titel
Die diabetischen Folgeerkrankungen
Mikro- und makroangiopathische Organschäden
verfasst von
U. D. Lichtenauer
J. Seissler
Prof. Dr. W. A. Scherbaum
Publikationsdatum
01.07.2003
Verlag
Springer-Verlag
Erschienen in
Die Innere Medizin / Ausgabe 7/2003
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI
https://doi.org/10.1007/s00108-003-0996-3

Weitere Artikel der Ausgabe 7/2003

Der Internist 7/2003 Zur Ausgabe

Schwerpunkt: Endorganschäden

Endorganschäden bei Entzündung und Sepsis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.